ArticleWorld journal of surgical oncology2023

PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma.

Libo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.